DAPK1 and acute kidney injury: Of note, combined treatment of DAPK1 inhibitor with ST2825 or administration of ST2825 into DAPK1 knockout mice provides synergistic protection against septic AKI, supporting further investigation and development of innovative combination-targeting therapeutic strategy for improving the clinical outcome of patients with septic AKI.